Skip to main content

Search

Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
Phase II study of neoadjuvant hormonal therapy guided by interval Ki67 testing in hormonal receptor-positive, HER2-negative breast cancer. King Abdullah Medical City (Makkah) Ongoing Letrozole (Femaplex) 2 20-718 King Abdullah Medical City (Makkah)
Modern Treatment of Inhibitor-PositiVe PATiEnts with Haemophilia A – An International Low-Interventional Pragmatic Investigator Initiated Trial Octapharma AG Ongoing Octanate, Wilate, Hemlibra, NovoSeven, Feiba 4 MOTIVATE King Abdulaziz Medical City NG (Riyadh)
Phase 1b/2 Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia Onyx Therapeutics, Inc., an Amgen Inc. Subsidiary Terminated Carfilzomib 2 20140106 King Fahad Medical City (Riyadh)
The Effectiveness of Sixteen Milligrams of Dexamethasone in Preventing Postoperative Nausea and Vomiting After Cesarean Delivery Under Neuroaxial Anesthesia King Khalid University Hospital Rejected Dexamethasone sodium phosphate 4 E-21-6388 King Khalid University Hospital (Riyadh)
Randomized, Prospective, Phase II clinical study of Intrathecal Morphine for patients undergoing elective Lumbar Spine Surgery under general anesthesia King Abdullah Medical City (Makkah) Ongoing MORPHINE SULPHATE 2 19-597 King Abdullah Medical City (Makkah)
Treatment of Cardio Vascular Disease with low dose Rivaroxaban in Advanced Chronic Kidney Disease(TRACK) KAIMRC Ongoing Rivaroxaban 3 SCT21R/008/10 King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah),King Khalid University Hospital (Riyadh)
Comparison of Three Times of Thyroid Hormone Replacement During Fasting the Month of Ramadan Among Patients with Total Thyroidectomy in Saudi Population: A Randomized Controlled Trial. King Fahd University Hospital Ongoing levothyroxine 4 E-21-5765 King Khalid University Hospital (Riyadh)
Ceftazidime-Avibactam versus Colistin in Critically Ill Patients with Carbapenem-Resistant Enterobacteriaceae Infections (AVI-ICU): A Randomized Clinical Trial King Faisal Specialist Hospital & Research Centre Ongoing Ceftazidime-avibactam 3 2211247 King Faisal Specialist Hospital and Research Center (Riyadh)
A Phase III, Randomized, Open-Label, Active-Controlled, Multicenter Study Evaluating The Efficiacy And Safety Of Crovalimab Versus Eculizumab In Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated with Complement Inhibitors Roche Ongoing Crovalimab 3 BO42161 King Faisal Specialist Hospital and Research Center (Riyadh)
A Phase III, Randomized, Open-Label, Active-Controlled, Multicenter Study Evaluating The Efficiacy And Safety Of Crovalimab Versus Eculizumab In Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors Roche Completed Crovalimab 3 BO42162 King Faisal Specialist Hospital and Research Center (Riyadh)
View 161 - 170 From 774